Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Dutch Life Sciences Trend Analysis 2017

Similar presentations


Presentation on theme: "The Dutch Life Sciences Trend Analysis 2017"— Presentation transcript:

1 The Dutch Life Sciences Trend Analysis 2017

2 About Us The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. The Dutch Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Holland BIO and Medical Delta. Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy.

3 Overview of the Dutch Life Science Industry
2017 Statistics Total Biotech companies 462 Medtech companies 122 Investor companies 29 HealthTech 39 Public / Non-Profit Organizations / Medical Facilities 181 Other life science related companies 877 Percentage of publicly owned companies 1.8% Life Sciences Venture Financing 2015/2016 USD 150.8m / 140.2m Number of technologies 162 Licensing opportunities 110

4 Overview of the Dutch Biotechnology Industry
2017 Statistics Total Biotech companies 462 Biotech - Therapeutics 103 Biotech – R&D Services 231 Biotech - Other 128 Percentage of SMEs 87% Percentage of publicly owned companies 1.8% Biotech Venture Financing 2015/2016 USD 124.8m / 71.2m Licensing opportunities 96

5 Number of Employees

6 Company Ownership Life Science companies include Biotech, Medtech and Pharmaceutical companies.

7 Company Foundation Timeline

8 Key Activities of Biotechnology Companies

9 Biotech Products - Breakdown by Therapeutic Area

10 Products in the Pipeline as of 15/03/2016

11 Biotechnology Financing in the Netherlands – 5 year report
Number of Rounds

12 Major Biotech Financing Rounds (2016)
Company Sector USD M Merus B.V. Biotechnology - Therapeutics and Diagnostics 47.3 argenx N.V. 33.7 17.4

13 About Biotechgate Biotechgate contains over 48,000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data. To register for a trial or to learn more about the different subscription options, please visit

14 Terms of Use The “Dutch Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof. The use of the figures and graphs provided in this report is free of charge for any presentations as long as is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse 11 8004 Zurich Switzerland +41 (43)


Download ppt "The Dutch Life Sciences Trend Analysis 2017"

Similar presentations


Ads by Google